LeisingerK.M. (2005) ‘The corporate social responsibility of the pharmaceutical industry: Idealism without illusion and realism without resignation’, Business Ethics Quarterly, 15(4), 577–594.
2.
De GeorgeR.T. (2005) ‘Intellectual property and pharmaceutical drugs: An ethical analysis’, Business Ethics Quarterly, 15(4), 549–575.
3.
HuberJ.BoyleP. (2005) ‘Roche's holistic approach to leadership communication’, Strategic Communication Management, 9(6), 18–21.
4.
RichterA.SchmidtS.L. (2005) ‘How does strategy process influence strategy content? Antecedents of consistency between resource allocation decisions and corporate strategy’, Schmalenbach Business Review (SBR), 57(4), 332–350.
5.
McDonaldM.SmithB.WardK. (2005) Marketing Due Diligence: Reconnecting Strategy to Share Price, Elsevier, London.
